Gelomics Raises $2.2M to Eliminate Animal Testing in Pharmaceutical R&D
AsiaTechDaily
JULY 7, 2024
Biotech startup Gelomics, headquartered in Brisbane, has secured $2.2 million in a pre-seed funding round led by early-stage investor Jelix Ventures.
Let's personalize your content